Mutation analysis of BrCA1, BrCA2, and p53 versus soluble HLA class I and class II in a case of familial endometriosis

article OA: closed CC0 ⤵ 7 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-09

This study analyzed mutations in BRCA1, BRCA2, and p53 genes alongside soluble HLA class I and class II levels in a familial case of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo investigate possible correlation(s) between mutations of BrCA1, BrCA2, and p53 genes versus soluble HLA expression in familial endometriosis.DesignMutation analysis.SettingUniversity teaching departments and hospital.Patient(s)A family with seven women in two generations with familial endometriosis.Intervention(s)Mutation analysis of BrCA1, BrCA2, and p53 genes.Main outcome measure(s)A point mutation of the BrCA1 gene appears to inhibit soluble HLA secretion.Result(s)Among the three genes examined, only the BrCA1 gene showed a T to A mutation at position 3232 that correlates with total abolishment of both class I and class II antigen release.Conclusion(s)A possible correlation between a BrCA1 mutation and soluble HLA expression appears to exist. The mutation is not stage dependent and seemingly influences the secretion of both class I and class II antigens that are totally absent from the serum of only one family member.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Genes, BRCA1 Genes, BRCA2 Genes, p53 Histocompatibility Antigens Class I Histocompatibility Antigens Class II Point Mutation Aged Aged, 80 and over Base Sequence DNA Mutational Analysis DNA Primers Endometriosis Exons Female Histocompatibility Antigens Class I Histocompatibility Antigens Class II Humans Major Histocompatibility Complex Middle Aged

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Cited by (7)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:55.732728+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK